Stockholm, May 31, 2022 - Intervacc announces today that Strangvac®, a vaccine against the highly contagious infectious disease equine strangles, has been released for sale in Denmark.
Press
The period in summary
First quarter January 1 – March 31, 2022
- On March 23 the first batch of Strangvac ... Read more
Stockholm, May 19, 2022 - Intervacc AB (publ) announces the initiation of a proof-of-concept study to measure the effectiveness of a vaccine to protect dairy cows against mastitis caused by Staphylococcus ... Read more
The shareholders of Intervacc AB (publ), reg. no. 556238-1748 (the “Company”), are hereby invited to the Annual General Meeting (“AGM”) to be held on Tuesday 14 June 2022 at 5.00 p.m. at Good Morning Hotel, ... Read more
In Norway it has not been allowed previously to vaccinate horses against strangles (infection caused by the bacterium Streptococcus equi). However, the Norwegian Food Safety Authority has now announced that the ... Read more